Table of Content

1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.2.1 Inclusion Criteria
1.2.2 Exclusion Criteria
1.3 Market Scope
1.3.1 Scope of the Study
1.3.2 Key Questions Answered in this Report
1.4 Research Methodology
1.4.1 Global Genomic Cancer Panel and Profiling Market: Research Methodology
1.4.2 Data Sources
1.4.3 Market Estimation Model
1.4.4 Criteria for Company Profiling
1.5 Market Overview
1.5.1 Market Definition
1.5.2 Market Footprint and Growth Potential
1.5.3 Future Potential

2 Industry Analysis
2.1 Legal Requirements
2.1.1 Regulation of Genetic Tests
2.1.2 NCCN Guidelines
2.1.3 Reimbursement Scenario
2.2 Patent Analysis
2.2.1 Patent Filing Trend
2.2.2 Patent Analysis (by Year)
2.2.3 Patent Analysis (by Country)

3 Market Dynamics
3.1 Overview
3.1.1 Impact Analysis
3.2 Market Drivers
3.2.1 Rising Need for Cancer Profiling in Developed Countries Driving Demand for Genomic Panels and Profiling Tests
3.2.2 Increase in Genomic Research Funding Expanding the Market for Genomic Cancer Panels and Profiling
3.2.3 Technological Advancements in the Field of Informatics Expanding Consumer Reach
3.3 Market Restraints
3.3.1 Significant Implications of Reimbursement Reductions Impacting Growth of the Genomic Cancer Panel and Profiling Market
3.3.2 Impact of High-Cost Pressure Hindering Development in Genomic Cancer Panel and Profiling Testing
3.4 Market Opportunities
3.4.1 Robust Pipeline of Genomic Cancer Panels and Profiling Tests Poised to Revolutionize Cancer Diagnosis
3.4.2 Discovery of New Biomarkers Presents an Opportunity for the Development of Diagnostics Tools and Technologies

4 Competitive Insights
4.1 Overview
4.2 Key Strategies and Developments
4.2.1 Product Launches, Approvals, and Upgradations
4.2.2 Synergistic Activities
4.2.3 Mergers and Acquisitions
4.2.4 Business Expansions, Funding, and Licenses
4.3 Growth-Share Analysis
4.3.1 Growth-Share Analysis (by Technology), 2022

5 By Tissue Testing
5.1 Overview
5.2 Solid Tissue Testing
5.3 Liquid Tissue Testing

6 By Cancer Panel Type
6.1 Overview
6.2 Single-Gene Panel
6.3 Multi-Gene Panel

7 By Cancer Type
7.1 Overview
7.2 Lung Cancer
7.3 Breast Cancer
7.4 Colon Cancer
7.5 Prostate Cancer
7.6 Other Cancers

8 By Application
8.1 Overview
8.2 Clinical
8.2.1 By Clinical
8.3 Research

9 By Technology
9.1 Overview
9.2 Next-Generation Sequencing (NGS)
9.3 Polymerase Chain Reaction (PCR)
9.4 Fluorescence In-Situ Hybridization (FISH)
9.5 Immunohistochemistry (IHC)
9.6 Others

10 By End User
10.1 Overview
10.2 Research and Academic Institutes
10.3 Clinical and Diagnostic Laboratories
10.4 Hospitals
10.5 Other End Users

11 By Region
11.1 Overview
11.2 North America
11.2.1 Key Dynamics
11.2.2 U.S.
11.2.3 Canada
11.3 Europe
11.3.1 Key Dynamics
11.3.2 Germany
11.3.3 France
11.3.4 U.K.
11.3.5 Italy
11.3.6 Spain
11.3.7 Rest-of-Europe
11.4 Asia-Pacific
11.4.1 Key Dynamics
11.4.2 China
11.4.3 Japan
11.4.4 India
11.4.5 Australia
11.4.6 South Korea
11.4.7 Rest-of-Asia-Pacific
11.5 Latin America
11.5.1 Key Dynamics
11.5.2 Brazil
11.5.3 Mexico
11.5.4 Rest-of-Latin America
11.6 Rest-of-the-World
11.6.1 Key Dynamics

12 Company Profiles
12.1 Overview
12.2 Agilent Technologies, Inc.
12.2.1 Company Overview
12.2.2 Role of Agilent Technologies, Inc. in the Global Genomic Cancer Panel and Profiling Market
12.2.3 Corporate Strategies
12.2.4 Financials
12.2.5 Analyst Perspective
12.3 ARUP Laboratories
12.3.1 Company Overview
12.3.2 Role of ARUP Laboratories in the Global Genomic Cancer Panel and Profiling Market
12.3.3 Corporate Strategies
12.3.4 Analyst Perspective
12.4 Burning Rock DX
12.4.1 Company Overview
12.4.2 Role of Burning Rock DX in the Global Genomic Cancer Panel and Profiling Market
12.4.3 Business Strategies
12.4.4 Analyst Perspective
12.5 Caris Life Sciences
12.5.1 Company Overview
12.5.2 Role of Caris Life Sciences in the Global Genomic Cancer Panel and Profiling Market
12.5.3 Corporate Strategies
12.5.4 Analyst Perspective
12.6 Danaher Corporation (Integrated DNA Technologies, Inc.)
12.6.1 Company Overview
12.6.2 Role of Danaher Corporation (Integrated DNA Technologies, Inc.) in the Global Genomic Cancer Panel and Profiling Market
12.6.3 Financials
12.6.4 Analyst Perspective
12.7 Exact Sciences Corporation
12.7.1 Company Overview
12.7.2 Role of Exact Sciences Corporation in the Global Genomic Cancer Panel and Profiling Market
12.7.3 Corporate Strategies
12.7.4 Business Strategies
12.7.5 Financials
12.7.6 Analyst Perspective
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Company Overview
12.8.2 Role of F. Hoffmann-La Roche Ltd in the Global Genomic Cancer Panel and Profiling Market
12.8.3 Corporate Strategies
12.8.4 Business Strategies
12.8.5 Financials
12.8.6 Analyst Perspective
12.9 Fulgent Genetics
12.9.1 Company Overview
12.9.2 Role of Fulgent Genetics in the Global Genomic Cancer Panel and Profiling Market
12.9.3 Financials
12.9.4 Analyst Perspective
12.1 Genecast Biotechnology Co., Ltd
12.10.1 Company Overview
12.10.2 Role of Genecast Biotechnology Co., Ltd in the Global Genomic Cancer Panel and Profiling Market
12.10.3 Analyst Perspective
12.11 Illumina, Inc.
12.11.1 Company Overview
12.11.2 Role of Illumina, Inc. in the Global Genomic Cancer Panel and Profiling Market
12.11.3 Corporate Strategies
12.11.4 Business Strategies
12.11.5 Financials
12.11.6 Analyst Perspective
12.12 Invitae Corporation
12.12.1 Company Overview
12.12.2 Role of Invitae Corporation in the Global Genomic Cancer Panel and Profiling Market
12.12.3 Corporate Strategies
12.12.4 Financials
12.12.5 Key Insights about the Financial Health of the Company
12.12.6 Analyst Perspective
12.13 Laboratory Corporation of America Holdings.
12.13.1 Company Overview
12.13.2 Role of Laboratory Corporation of America Holdings. in Global Genomic Cancer Panel and Profiling Market
12.13.3 Corporate Strategies
12.13.4 Business Strategies
12.13.5 Financials
12.13.6 Analyst’s Perspective
12.14 Paragon Genomics
12.14.1 Company Overview
12.14.2 Role of Paragon Genomics in the Global Genomic Cancer Panel and Profiling Market
12.14.3 Analyst Perspective
12.15 Tempus
12.15.1 Company Overview
12.15.2 Role of Tempus in the Global Genomic Cancer Panel and Profiling Market
12.15.3 Analyst Perspective
12.16 Thermo Fisher Scientific Inc.
12.16.1 Company Overview
12.16.2 Role of Thermo Fisher Scientific Inc. in the Global Genomic Cancer Panel and Profiling Market
12.16.3 Financials
12.16.4 Analyst Perspective
List of Figures
Figure 1: Global Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 2: Global Genomic Cancer Panel and Profiling Market (by Tissue Testing), % Share, 2022 and 2033
Figure 3: Global Genomic Cancer Panel and Profiling Market (by Cancer Panel Type), % Share, 2022 and 2033
Figure 4: Global Genomic Cancer Panel and Profiling Market (by Cancer Type), % Share, 2022 and 2033
Figure 5: Global Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
Figure 6: Global Genomic Cancer Panel and Profiling Market (by Technology), % Share 2022 and 2033
Figure 7: Global Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
Figure 8: Global Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
Figure 9: Global Genomic Cancer Panel and Profiling Market Segmentation
Figure 10: Global Genomic Cancer Panel and Profiling Market: Research Methodology
Figure 11: Primary Research Methodology
Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
Figure 13: Top-Down Approach (Segment-Wise Analysis)
Figure 14: Genomic Cancer Panel and Profiling Workflow, End User Perspective
Figure 15: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
Figure 16: Global Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 17: General Testing Criterion According to the NCCN Guidelines
Figure 18: Reimbursement Components in the U.S.
Figure 19: Global Genomic Cancer Panel and Profiling Market, Patent Analysis (by Year), January 2020-October 2023
Figure 20: Global Genomic Cancer Panel and Profiling Market, Patent Analysis (by Country), January 2020-October 2023
Figure 21: Global Genomic Cancer Panel and Profiling Market Dynamics
Figure 22: Cancer Profiling Cases in Developed Countries
Figure 23: Share of Global Cancer Prevalence, 2010-2019
Figure 24: Share of Global Age-Standardized Death Rate of Cancer, 2010-2019
Figure 25: Genomic Research Funding by National Human Genome Research Institute (NHGRI), $Million, 2020, 2021, and 2022
Figure 26: Key Players Offering
Figure 27: Reimbursement Reductions Adopted for Oncology Testing as per PAMA Revisions
Figure 28: Cost Difference between the Multi-Gene Panel Test and Usual Care Screening Test
Figure 29: Share of Key Developments, January 2020-October 2023
Figure 30: Number of Product Launches, Approvals, and Upgradations (by Company), January 2020-October 2023
Figure 31: Growth-Share Analysis of the Global Genomic Cancer Panel and Profiling Market (by Technology), 2022
Figure 32: Global Genomic Cancer Panel and Profiling Market (by Tissue Testing)
Figure 33: Global Genomic Cancer Panel and Profiling Market (by Tissue Testing), % Share, 2022 and 2033
Figure 34: Global Genomic Cancer Panel and Profiling Market (Solid Tissue Testing), $Billion, 2022-2033
Figure 35: Global Genomic Cancer Panel and Profiling Market (Liquid Tissue Testing), $Billion, 2022-2033
Figure 36: Global Genomic Cancer Panel and Profiling Market (by Cancer Panel Type)
Figure 37: Global Genomic Cancer Panel and Profiling Market (by Cancer Panel Type), % Share, 2022 and 2033
Figure 38: Global Genomic Cancer Panel and Profiling Market (Single-Gene Panel), $Billion, 2022-2033
Figure 39: Global Genomic Cancer Panel and Profiling Market (Multi-Gene Panel), $Billion, 2022-2033
Figure 40: Global Genomic Cancer Panel and Profiling Market (by Cancer Type)
Figure 41: Global Genomic Cancer Panel and Profiling Market (by Cancer Type), % Share, 2022 and 2033
Figure 42: Global Genomic Cancer Panel and Profiling Market (Lung Cancer), $Billion, 2022-2033
Figure 43: Global Genomic Cancer Panel and Profiling Market (Breast Cancer), $Billion, 2022-2033
Figure 44: Global Genomic Cancer Panel and Profiling Market (Colon Cancer), $Billion, 2022-2033
Figure 45: Estimated New Cancer Cases and Deaths for Prostate Cancer, 2022
Figure 46: Global Genomic Cancer Panel and Profiling Market (Prostate Cancer), $Billion, 2022-2033
Figure 47: Global Genomic Cancer Panel and Profiling Market (Other Cancers), $Billion, 2022-2033
Figure 48: Global Genomic Cancer Panel and Profiling Market (by Application)
Figure 49: Global Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
Figure 50: Global Genomic Cancer Panel and Profiling Market (Clinical), $Billion, 2022-2033
Figure 51: Global Genomic Cancer Panel and Profiling Market (by Clinical), $Million, 2022-2033
Figure 52: Global Genomic Cancer Panel and Profiling Market (Research), $Billion, 2022-2033
Figure 53: Global Genomic Cancer Panel and Profiling Market (by Technology)
Figure 54: Global Genomic Cancer Panel and Profiling Market (by Technology), % Share, 2022 and 2033
Figure 55: Global Genomic Cancer Panel and Profiling Market (Next-Generation Sequencing), $Billion, 2022-2033
Figure 56: Global Genomic Cancer Panel and Profiling Market (Polymerase Chain Reaction), $Billion, 2022-2033
Figure 57: Global Genomic Cancer Panel and Profiling Market (Fluorescence In-Situ Hybridization), $Billion, 2022-2033
Figure 58: Global Genomic Cancer Panel and Profiling Market (Immunohistochemistry), $Billion, 2022-2033
Figure 59: Global Genomic Cancer Panel and Profiling Market (Others), $Billion, 2022-2033
Figure 60: Global Genomic Cancer Panel and Profiling Market (by End User)
Figure 61: Global Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
Figure 62: Global Genomic Cancer Panel and Profiling Market (Research and Academic Institutes), $Billion, 2022-2033
Figure 63: Global Genomic Cancer Panel and Profiling Market (Clinical and Diagnostics Laboratories), $Billion, 2022-2033
Figure 64: Global Genomic Cancer Panel and Profiling Market (Hospitals), $Billion, 2022-2033
Figure 65: Global Genomic Cancer Panel and Profiling Market (Other End Users), $Billion, 2022-2033
Figure 66: Global Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
Figure 67: North America Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 68: North America Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 69: North America Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 70: North America Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
Figure 71: U.S. Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 72: Canada Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 73: Europe Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 74: Europe Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 75: Europe Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 76: Europe Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
Figure 77: Germany Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 78: France Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 79: U.K. Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 80: Italy Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 81: Spain Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 82: Rest-of-Europe Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 83: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 84: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 85: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 86: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
Figure 87: China Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 88: Japan Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 89: India Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 90: Australia Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 91: South Korea Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 92: Rest-of-Asia-Pacific Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 93: Latin America Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 94: Latin America Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 95: Latin America Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 96: Latin America Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
Figure 97: Brazil Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 98: Mexico Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 99: Rest-of-Latin America Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 100: Rest-of-the-World Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 101: Rest-of-the-World Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 102: Rest-of-the-World Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 103: Global Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
Figure 104: Agilent Technologies, Inc.: Product Portfolio
Figure 105: Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 106: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 107: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 108: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 109: ARUP Laboratories: Overall Product Portfolio
Figure 110: Burning Rock DX: Product Portfolio
Figure 111: Caris Life Sciences: Overall Product Portfolio
Figure 112: Danaher Corporation (Integrated DNA Technologies, Inc.): Product Portfolio
Figure 113: Danaher Corporation (Integrated DNA Technologies, Inc.): Overall Financials, $Million, 2020-2022
Figure 114: Danaher Corporation (Integrated DNA Technologies, Inc.): Revenue (by Segment), $Million, 2020-2022
Figure 115: Danaher Corporation (Integrated DNA Technologies, Inc.): Revenue (by Region), $Million, 2020-2022
Figure 116: Danaher Corporation (Integrated DNA Technologies, Inc.): R&D Expenditure, $Million, 2020-2022
Figure 117: Exact Sciences Corporation: Product Portfolio
Figure 118: Exact Sciences Corporation: Overall Financials, $Million, 2019-2021
Figure 119: Exact Sciences Corporation: Revenue (by Segment), $Million, 2019-2021
Figure 120: Exact Sciences Corporation: Revenue (by Region), $Million, 2019-2021
Figure 121: Exact Sciences Corporation: R&D Expenditure, $Million, 2019-2021
Figure 122: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 123: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2020-2022
Figure 124: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2020-2022
Figure 125: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2020-2022
Figure 126: Fulgent Genetics: Product Portfolio
Figure 127: Fulgent Genetics: Overall Financials, $Million, 2020-2022
Figure 128: Fulgent Genetics: Revenue (by Region), $Million, 2020-2022
Figure 129: Fulgent Genetics: R&D Expenditure, $Million, 2020-2022
Figure 130: Genecast Biotechnology Co., Ltd: Product Portfolio
Figure 131: Illumina, Inc.: Product Portfolio
Figure 132: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 133: Illumina, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 134: Illumina, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 135: Illumina, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 136: Invitae Corporation: Overall Product Portfolio
Figure 137: Invitae Corporation: Overall Financials, $Million, 2020-2022
Figure 138: Invitae Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 139: Invitae Corporation: Revenue (by Region), $Million, 2020-2022
Figure 140: Invitae Corporation: R&D Expenditure, $Million, 2020-2022
Figure 141: Laboratory Corporation of America Holdings.: Product Portfolio
Figure 142: Laboratory Corporation of America Holdings.: Overall Financials, $Million, 2020-2022
Figure 143: Laboratory Corporation of America Holdings.: Revenue (by Segment), $Million, 2020-2022
Figure 144: Laboratory Corporation of America Holdings.: Revenue (by Region), $Million, 2020-2022
Figure 145: Paragon Genomics: Product Portfolio
Figure 146: Tempus: Product Portfolio
Figure 147: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 148: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
Figure 149: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 150: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
Figure 151: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
List of Tables
Table 1: Global Genomic Cancer Panel and Profiling Market, Impact Analysis
Table 2: Technological Trends in the Global Genomic Cancer Panel and Profiling Market
Table 3: Global Genomic Cancer Panel and Profiling Market, Impact Analysis
Table 4: Global Genomic Cancer Panel and Profiling Market, Pipeline Tests
Table 5: Ongoing Cancer-Based Biomarkers Trials
Table 6: North America Genomic Cancer Panel and Profiling Market, Impact Analysis
Table 7: Europe Genomic Cancer Panel and Profiling Market, Impact Analysis
Table 8: Asia-Pacific Genomic Cancer Panel and Profiling Market, Impact Analysis
Table 9: Latin America Genomic Cancer Panel and Profiling Market, Impact Analysis
Table 10: Rest-of-the-World Genomic Cancer Panel and Profiling Market, Impact Analysis